Search the Newsreel

Himalaya Shipping Ltd. (HSHP) Announces its Preliminary Results for the Three and Six Months Ended June 30, 2026

Himalaya Shipping Ltd. announced its preliminary unaudited results for the second quarter of 2026, reporting total time-charter revenues of $53.3 million, net income of $24.6 million, and EBITDA of $44.0 million. The company also detailed new time charter agreements and converted some index-linked charters …

Himalaya Shipping Ltd. (HSL) – Special General Meeting Results Notification

Himalaya Shipping Ltd. (NYSE: HSHP, Euronext Growth Oslo: HSHP) announced the results of its Special General Meeting held on August 10, 2026. Shareholders approved a resolution to reduce the Company's Share Premium account by US$28,500,000, transferring this amount to the Contributed Surplus account. This …

Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock

Elanco Animal Health (NYSE:ELAN) Director Paul Herendeen recently purchased 10,000 shares of the company's stock for $236,800, increasing his total ownership to 111,687 shares. This insider buying follows Elanco's strong quarterly earnings report, where the company beat estimates with $0.34 EPS and saw revenue …

ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance

Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026

David Glenn, CFO of Phibro Animal Health Corp (NASDAQ: PAHC), was awarded 3,334 restricted stock units (RSUs) of Class A Common Stock on August 6, 2026. The filing for this acquisition was made on August 10, 2026, with the RSUs valued at $0.

Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer

Phibro Animal Health Corp (PAHC) has granted 3,522 restricted stock units (RSUs) to its Chief Operating Officer, Larry Lee Miller. These RSUs, representing Class A Common Stock, will vest in three equal installments over three years, contingent on his continued employment. Following this grant, …

Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim

Phibro Animal Health (PAHC) director Jonathan Bendheim was granted 2,716 restricted stock units (RSUs) on August 6, 2026. These RSUs represent a contingent right to receive one share of Class A Common Stock each, and they will vest in substantially equal installments on the …

Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded 2,478 Restricted Stock Units (RSUs) to Judith Weinstein, its Senior Vice President and General Counsel. This grant increases her direct holdings to 5,453 shares. The RSUs will vest in substantially equal installments over three years, beginning …

Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant

Phibro Animal Health (NASDAQ: PAHC) CFO David Glenn was granted 3,334 restricted stock units (RSUs). These RSUs, which represent Class A Common Stock, were awarded at a price of $0.00 per share and will vest in three equal annual installments starting August 1, 2026, …

Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources

Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. …

Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO

Phibro Animal Health (PAHC) reported that its President and CEO, Daniel M. Bendheim, was granted 11,699 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of Class A Common Stock each, vesting in three equal annual installments beginning August …

Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on …

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, …

Magellan Aerospace (TSE:MAL) Hits New 12-Month High - Here's Why

Kwality Pharma, Aarti Pharmalabs, Universal Cables hit 20% upper circuits

Aarti Pharmalabs Q1 Results: Consolidated Net Profit Rises 65% YoY

Aarti Pharmalabs Ltd leads gainers in 'A' group

Malibu Boats Inc (MBUU) Earnings Forecast: Future EPS & Revenue Growth Estimates

Amalgamated Bank (AMAL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore

Aarti Pharmalabs hits the roof after Q1 PAT rises 65% YoY

Mallcom (India) Consolidated June 2026 Net Sales at Rs 109.49 crore, down 10.57% Y-o-Y

Elanco Animal Health Number of Employees 2026 | Employee Count & Headcount Data

Elanco Animal Health (ELAN) had approximately 10,025 employees worldwide as of March 2026, marking a 2.8% growth since 2023. The company is actively hiring, with 772 job postings in 2026, a 40.1% increase from 2025. Its workforce is primarily concentrated in North America, and …

Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win?

Elanco Animal Health (ELAN) reported stronger Q2 sales and net income, along with an FDA Emergency Use Authorization for its CLiK Extra screwworm-prevention spray. The company also raised its full-year revenue guidance, positioning it as a key player in addressing the New World screwworm …

Earnings Troubles May Signal Larger Issues for Tourmaline Oil (TSE:TOU) Shareholders

Is Magellan Aerospace (TSX:MAL) Quietly Recasting Its Capital Allocation Playbook With This Dividend Move?

Aarti Pharmalabs Q1 Results: Consolidated revenue surges 118% YoY

Aarti Pharmalabs Publishes Q1 FY27 Financial Results in Newspapers

Price to earnings forward of Capital Small Finance Bank Limited – NSE:CAPITALSFB

Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Is Elanco Animal Health (ELAN) Undervalued Following Its FDA Emergency Use Authorization?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Understanding the Setup: (AMAL) and Scalable Risk

This article analyzes Amalgamated Financial Corp. (NASDAQ: AMAL), highlighting strong sentiment across all horizons supporting an overweight bias. It details an exceptional 23.9:1 risk-reward short setup with a 7.0% downside target against a 0.3% risk. The analysis includes three distinct AI-generated trading strategies for …

Heineken Malaysia Berhad (KLSE:HEIM) Analysts Are More Bearish Than They Used To Be

MarketsMOJO Downgrades Harrisons Malayalam Ltd to Sell on Valuation and Financial Concerns

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Elanco Animal Health (NYSE:ELAN) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $29.09, significantly above its current share price of $22.06. The company recently surpassed quarterly earnings expectations, reporting adjusted EPS of $0.34 on revenues of …

Elanco Animal Health Q2 Earnings Call Highlights

Key Points Interested in Elanco Animal Health Incorporated? Here are five stocks we like better. Strong Q2 performance: Elanco reported revenue of $1.368 billion, up 10% year over year, while adjusted EBITDA rose 21% to $288 million and adjusted EPS increased 31% to $0.34. …